Dermata Therapeutics, Inc. DRMA
0.71 USD -0.06 (-7.21%)
At closeNov 10, 2026, 4:21 PM EST
0.74 +0.02 +2.98%
After hours · Nov 10, 4:21 PM ET
0.7136 Day range 0.778
0.603 52-week range 4.66
- YTD
- -69.20%
- 1 year
- -77.81%
News
benzinga.com Dermata Therapeutics Q3 EPS $(0.55), Inline Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.55) per share which met the analyst consensus estimate. This is a 66.67 percent increase over losses of $(1.65) per share from the…
benzinga.com Dermata Therapeutics Enrolls First Participant In Its Clinical Trial Evaluating Tome Clearing Treatment For Acne; Expects To Launch This Second Commercial Product In H1 2027 The initiation of this clinical trial marks another milestone in Dermata's strategy by adding a second product to its Tome skincare portfolio, targeting significant opportunities in the consumer…
benzinga.com Why Is Dermata Therapeutics Stock Gaining Thursday? Dermata Therapeutics (DRMA) jumps 34% after positive clinical results for its weekly Bioneedle Tome Foundational Treatment.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 30.4% to $10.58 during Thursday's regular session. The company's market cap stands at $4.0 billion. SenesTech (NASDAQ:SNES) stock rose…
benzinga.com Dermata Therapeutics Announces Over 71% Of Patients Had Overall Skin Improvements At Day 29 In Its Cosmetic Clinical Trial Of Tome Foundational Treatment Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced positive topline results from its recently completed cosmetic
accessnewswire.com Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment - Once-weekly Tome Foundational Treatment demonstrated improvements across key measures of skin appearance after four treatments - - Over 71% of study participants were graded as having overall…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's after-market session. The company's market cap stands at $1.4 billion. The company's, Q4 earnings came out…
accessnewswire.com Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment - Tome Foundational Treatment, powered by Bioneedle™, is now available for purchase at www.tomeskincare.com - - Once-weekly Foundational Treatment is designed to renew the appearance of skin and…
accessnewswire.com Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch - Preorders can be made by visiting www.tomeskincare.com - - Dermata is ready to begin shipping orders on the expected launch date of August 25, 2026 - - Tome Foundational Treatment is a once-weekly…
accessnewswire.com Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules $3.4 million upfront with up to approximately $6.7 million of potential additional gross proceeds upon the exercise in full of warrants SAN DIEGO, CA / ACCESS Newswire / August 17, 2026 / Dermata…- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular session. The market value of their outstanding shares is at $9.5 million. Sionna Therapeutics (NASDAQ:SION)…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million. Definium Therapeutics
benzinga.com Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? Dermata Therapeutics shares jumped 28.73% pre-market after reporting second-quarter results and preparing for its upcoming skincare product launch.
benzinga.com Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket CRWV shares rose in pre-market trading after reporting better-than-expected Q2 results. BAOS, BOXL, DOGZ, DRMA, ZBAO, HYLN, XHLD, VELO, and HRB also saw gains.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2…
accessnewswire.com Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - Dermata announced the launch date of its first commercial product, Tome™ Foundational Treatment, expected on August 25, 2026 - - Dermata recently attended Be+Well Beauty and Wellness Show in Las…
accessnewswire.com Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - A new chapter in skincare has arrived - - This will be Dermata's first commercial product launch, planned for August 25, 2026 - - Join the waitlist at tomeskincare.com - SAN DIEGO, CA / ACCESS…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Dermata Therapeutics Q1 EPS $(0.48) Beats $(0.53) Estimate Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.53) by 9.43 percent. This is a 89.33 percent increase over losses of…
accessnewswire.com Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 - Dermata announced their Tome Skincare brand for direct-to-consumer ("DTC") skincare products - - Dermata plans to launch its first DTC product, the Tome Foundational Treatment, a once-weekly mask…- benzinga.com Dermata Therapeutics Secures Australian Patent Acceptance For Bioneedle System In Dermal Fillers - This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers -- The Company also has allowed and issued patents in the US,…
accessnewswire.com Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System - This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers - - The Company also has allowed and issued patents in the US,…
benzinga.com Dermata Therapeutics Q4 EPS $(1.52) Beats $(1.54) Estimate Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(1.52) per share which beat the analyst consensus estimate of $(1.54) by 1.3 percent. This is a 83.48 percent increase over losses of…
accessnewswire.com Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Dermata announced a strategic pivot to develop and commercialize direct-to-consumer ("DTC") skincare products under the brand name Tome - - Dermata plans to launch its first DTC product, our…
defenseworld.net Head-To-Head Review: Pliant Therapeutics (NASDAQ:PLRX) versus Dermata Therapeutics (NASDAQ:DRMA) Dermata Therapeutics (NASDAQ: DRMA - Get Free Report) and Pliant Therapeutics (NASDAQ: PLRX - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance Dermata Therapeutics shares are trading higher Friday after the USPTO issued a notice of allowance for a patent on skin condition treatment.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket Planet Labs (PL) stock rose in pre-market trading after better-than-expected Q4 sales and strong FY27 guidance. Top gainers include JDZG, AZTR, YYGH, DRMA, WNW, RPGL, JEM, FDX, and FLY. Top losers…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
benzinga.com UPDATE: Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS" 
accessnewswire.com Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Kyra Peckaitis will lead the launch of Dermata's recently announced Tome skincare brand - SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / Dermata Therapeutics, Inc. ("Dermata," or the "Company")…
defenseworld.net Dermata Therapeutics (DRMA) Projected to Post Earnings on Monday Dermata Therapeutics (NASDAQ: DRMA - Get Free Report) is expected to issue its results before the market opens on Monday, March 16th. Analysts expect the company to announce earnings of ($1.54) per…
accessnewswire.com Dermata Opens a New Chapter with the Release of Tome Skincare -The oldest new thing in skincare - - Dermata expects to launch its first product in the middle of 2026 - SAN DIEGO, CA / ACCESS Newswire / March 5, 2026 / Dermata Therapeutics, Inc.…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Comfort Systems Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com The Australian Patent Office Grants Dermata Therapeutics' Patent Application for Its Spongilla Technology Combination as a Method for Treating Acne The Company's innovative acne kit represents a new approach to acne treatment by targeting the underlying acne-causing mechanisms with enhanced precision and effectiveness. Unlike traditional…
accessnewswire.com Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office This patent grant follows the Company's U.S. issued patent, covering its Spongilla technology combination as a method to topically treat acne Dermata expects to launch a new once-weekly,…
benzinga.com Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
feeds.benzinga.com Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus U.S. stock futures swung between gains and losses on Tuesday after Monday's declines. Futures of major benchmark indices were mixed. The Santa Claus rally, which began on Dec. 24 last week, seems to…
benzinga.com Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus U.S. stock futures swung between gains and losses on Tuesday after Monday’s declines. Futures of major benchmark indices were mixed. The Santa Claus rally, which began on Dec. 24 last week, seems to…
benzinga.com Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket